Pancreatic Cancer Research

ResearcherUniversity Hospital ZurichActive in the last 2 years

Povilas Ignatavičius

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0000-0002-6112-6235; OpenAlex author ID A5056512748, A5121805660. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 8

  1. Circulating cell-free DNA fragmentomics distinguishes pancreatic ductal adenocarcinoma from non-malignant conditions Last author DOI 10.1007/s00423-026-04267-0↗
  2. Overexpression of EMT-related transcription factors SNAI1 and ZEB1 is associated with more aggressive clinicopathological features of pancreatic cancer. Co-author DOI 10.1371/journal.pone.0339964↗
  3. Circulating Cell-Free DNA as a Potential Diagnostic Tool in Pancreatic Cancer: A Comparative Analysis. Last author DOI 10.1159/000547870↗
  4. Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Measuring Perfusion in Pancreatic Ductal Adenocarcinoma and Different Tumor Grade: A Preliminary Singl… Co-author DOI 10.3390/diagnostics13030521↗
  5. Dynamic Perfusion Computed Tomography and Apparent Diffusion Coefficient as Potential Markers for Poorly Differentiated Pancreatic Adenocarcinoma. Co-author DOI 10.1159/000511973↗
  6. Dynamic perfusion CT - A promising tool to diagnose pancreatic ductal adenocarcinoma. Co-author DOI 10.1515/med-2021-0228↗
  7. Preoperative Platelet to Lymphocyte Ratio as a Prognostic Factor for Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. First author DOI 10.1159/000508444↗
  8. CT- and MRI-Based Assessment of Body Composition and Pancreatic Fibrosis Reveals High Incidence of Clinically Significant Metabolic Changes That Affect the Qua… Co-author DOI 10.3390/medicina55100649↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Giedrius Barauskas · 8 shared papers, 2019–2026 · strength 1.72
  2. Antanas Gulbinas · 4 shared papers, 2019–2026 · strength 0.85
  3. Romualdas Riauka · 3 shared papers, 2020–2026 · strength 0.75
  4. Žilvinas Dambrauskas · 3 shared papers, 2019–2026 · strength 0.71
  5. Inga Zaborienė · 3 shared papers, 2021–2023 · strength 0.55
  6. Kristina Žvinienė · 3 shared papers, 2021–2023 · strength 0.55
  7. Kęstutis Urbonas · 1 shared paper, 2026 · strength 0.33
  8. Darius Stukas · 1 shared paper, 2026 · strength 0.29
  9. Arenida Bartkevičienė · 1 shared paper, 2026 · strength 0.29
  10. Edita Bieliūnienė · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.